Disposition of 19864 shares by Peter Rahmer of Relay Therapeutics at 6.47 subject to Rule 16b-3

Read at macroaxis.com

Published few days ago View all stories for Driehaus Micro | Driehaus Micro Hype Analysis

Disposition of 19864 common stock at 6.47 of Relay Therapeutics by Peter Rahmer on 25th of November 2024. This event was filed by Relay Therapeutics with SEC on 2024-06-03. Statement of changes in beneficial ownership - SEC Form 4

We analyze Driehaus Micro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Driehaus Micro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Driehaus Micro based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Driehaus Micro mutual fund to make a market-neutral strategy. Peer analysis of Driehaus Micro could also be used in its relative valuation, which is a method of valuing Driehaus Micro by comparing valuation metrics with similar companies.

Driehaus Micro financial ratios help investors to determine whether Driehaus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Driehaus with respect to the benefits of owning Driehaus Micro security.